Insmed Incorporated (insm)
INSM Ownership
Institutional holdings, insider activity, and 13F data for Insmed Incorporated are premium features in Vest Terminal.
Ownership & insider analytics is available in Vest Terminal for Professional and Enterprise subscribers.
Start Free — open INSM in Vest Terminal
Access live data, filings, ownership, and analysis for Insmed Incorporated.
Insmed Incorporated FAQ
What does Insmed Incorporated (INSM) do?
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is…
What is INSM's P/E ratio?
Insmed Incorporated has a trailing P/E of N/A× based on publicly available market data.
Does INSM pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is INSM in?
Insmed Incorporated is classified in Healthcare (Biotechnology) on NMS.
What is INSM's market capitalization?
Approximate market cap: $25.84B.
What are the main risks for INSM?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of INSM?
Potential positives include revenue growth of 3.0% year-over-year, gross margin of 83.5% supports competitive unit economics.
Where can I get analyst estimates for INSM?
Public analyst price targets and consensus for Insmed Incorporated are on the free /stocks/insm/estimates page. Deeper estimate history and models are available in Vest Terminal.